Tradestie Institutional Equity Comparison Engine
MGNX vs MESO โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
MGNX Overall Edge
MGNX Captures Institutional Edge (4โ0 Pillars ยท 6โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to MacroGenics, Inc. (MGNX) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, MGNX trades at 61.0x Forward P/E with -21.7% operating margin (+378.0% YoY revenue) versus MESO at N/M Forward P/E and -42.6% operating margin (+390.7% YoY). In options structure, MGNX sits in BREAKDOWN (1st %ile IV; Dealer Gamma Walls on Pro) against MESO sits in UNCLASSIFIED (37th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
MGNX
MGNX 61.0x vs MESO N/M Fwd P/E
Growth & Margin Winner
MGNX
Op Margin -21.7% vs -42.6% ยท YoY +378.0% vs +390.7%
Momentum & Technical Winner
MGNX
1Y +26.6% vs -16.4% ยท 52W Pos 19% vs 6%
Options & Structure Winner
MGNX
BREAKDOWN (1st %ile IV) vs UNCLASSIFIED (37th %ile IV)
MGNX
NASDAQ
MacroGenics, Inc.
Pharmaceutical Preparations
$2.02
-7.95% 1D
Market Cap
$145.9M
1M Return
-37.69%
1Y Return
+26.56%
Forward P/E
61.0x
Unified AI Score
43.6 / 100
HOLD
Tech 25.0
Fund 46.0
Flow 65.0
Mom 55.0
MESO
NASDAQ
Mesoblast Limited American Depositary Shares
Biological Products, (No Diagnostic Substances)
$12.47
-6.03% 1D
Market Cap
$1.7B
1M Return
-6.1%
1Y Return
-16.42%
Forward P/E
N/M
Unified AI Score
35.5 / 100
SELL
Tech 25.0
Fund 40.0
Flow 50.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
MGNX +26.56%
MESO -16.42%
Spread: +42.98 pp (MGNX Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
MGNX TTM Op. Margin: -21.7%
MESO TTM Op. Margin: -42.6%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MGNX vs MESO. Trailing 12-month operating profitability (MGNX -21.7% vs MESO -42.6%) and valuation multiples (MGNX 61.0x vs MESO N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | MGNX | MESO | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $145.9M | $1.7B | Larger Scale | MESO |
| Trailing P/E Ratio Valuation | 61.0x | N/M | Lower Multiple | MGNX |
| Forward P/E Ratio Valuation | 61.0x | N/M | Lower Multiple | MGNX |
| Revenue Growth (YoY) Growth | +378.0% | +390.7% | Higher Growth | MESO |
| Operating Margin (TTM) Profitability | -21.7% | -42.6% | Higher Margin | MGNX |
| Net Profit Margin Profitability | -8.3% | -47.8% | Higher Margin | MGNX |
| Return on Equity (ROE) Capital Efficiency | -225.9% | -9.9% | Higher ROE | MESO |
| 52-Week Range Position Momentum | 19% ($1โ$5) | 6% ($12โ$22) | Stronger Trend | MGNX |
| Beta / 30D Volatility Risk Regime | 1.37ฮฒ ยท 148% Vol | 1.18ฮฒ ยท 78% Vol | Lower Realized Risk | MESO |
| Unified Institutional Score Composite Signal | 43.6 / 100 (HOLD) | 35.5 / 100 (SELL) | Higher Composite | MGNX |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full MGNX vs MESO Buy Guide
MGNX
BREAKDOWN
122d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
1st %ile
IV Regime
Compressed (<25th %ile)
MESO
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
37th %ile
IV Regime
Balanced (25thโ60th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither MGNX nor MESO registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.